Jones Hill Capital LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0002102314

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 Q2 2026 Q1 2026

Q1 2026 · 26 positions · Total reported value $466.47M · Top-10 concentration 73.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 81.2% · 19 new · 5 cut · 15 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -10.3% · vs SPY -12.4% · Prev Value $470.36M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -7.4% · vs SPY -9.6% · Latest Value $589.17M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, Jones Hill Capital LP disclosed 26 equity positions with a combined reported value of $466.47M. The filing implies a focused portfolio: its ten largest positions account for 73.1% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were BMRN ($71.65M), VRTX ($48.50M), PCVX ($37.47M). By sector, the heaviest allocations are Health Care 87.5%, Other 12.5%.

Versus the prior quarter, Jones Hill Capital LP opened 19 new positions, trimmed 5 and fully exited 15, a turnover rate of 81.2% of positions.

The largest new positions opened in Q1 2026 were BMRN ($71.65M), VRTX ($48.50M), PCVX ($37.47M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • BMRN BIOMARIN PHARMACEUTICAL INC · $71.65M
  • VRTX VERTEX PHARMACEUTICALS INC · $48.50M
  • PCVX VAXCYTE INC · $37.47M
  • NUVL NUVALENT INC · $30.82M
  • CAPR CAPRICOR THERAPEUTICS INC · $27.64M
  • TERN TERNS PHARMACEUTICALS INC · $27.48M
  • BCAX BICARA THERAPEUTICS INC · $25.06M
  • ANIP ANI PHARMACEUTICALS INC · $24.50M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Jones Hill Capital LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Jones Hill Capital LP, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 29 positions worth $470.36M in total. HoldingsHub carries 2 quarters of its filings (Q1 2026–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-135105 (status: Approved), registered 2026-01-06
  • Regulatory AUM (Form ADV): $642.42M as of 2026-05-06
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: joneshillcapital.com

Portfolio Structure

  • 29 positions · $470.36M reported value (Q2 2026)
  • Top 10 holdings = 68.8% of reported value
  • Largest position: BMRN (BIOMARIN PHARMACEUTICAL INC) at 17.4%
  • Average position size: $16.22M

Sector Tilt

  • Health Care 97.4%
  • (classified holdings cover 97% of value)

Quarterly Activity

  • Q2 2026: 15 new, 5 added, 9 reduced, 12 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 87.5%
Other 12.5%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.27M $71.65M 15.36%
15.36%
New
2 108.60K $48.50M 10.40%
10.40%
New
3 644.83K $37.47M 8.03%
8.03%
New
4 300.83K $30.82M 6.61%
6.61%
New
5 909.21K $27.64M 5.92%
5.92%
New
6 521.24K $27.48M 5.89%
5.89%
New
7 1.26M $25.06M 5.37%
5.37%
New
8 318.59K $24.50M 5.25%
5.25%
New
9 1.17M $24.42M 5.24%
5.24%
New
10 593.04K $23.25M 4.98%
4.98%
New
11 1.60M $22.22M 4.76%
4.76%
New
12 26.00K $18.98M 4.07%
4.07%
New
13 1.77M $13.59M 2.91%
2.91%
New
14 1.20M $10.74M 2.30%
2.30%
New
15 2.38M $10.22M 2.19%
2.19%
New
16 140.84K $6.91M 1.48%
1.48%
New
17 513.05K $6.70M 1.44%
1.44%
New
18 100.84K $6.37M 1.36%
1.36%
New
19 452.12K $6.22M 1.33%
1.33%
New
20 100.59K $4.85M 1.04%
1.04%
New
21 374.01K $4.72M 1.01%
1.01%
New
22 167.01K $4.72M 1.01%
1.01%
New
23 370.18K $4.42M 0.95%
0.95%
New
24 342.75K $2.39M 0.51%
0.51%
New
25 301.60K $1.59M 0.34%
0.34%
New
26 45.81K $1.06M 0.23%
0.23%
New

FAQ

What did Jones Hill Capital LP buy in 2026-Q1?

In its 2026-Q1 13F filing, Jones Hill Capital LP reported 26 equity positions worth $466.47M in aggregate; its largest disclosed positions were BMRN ($71.65M), VRTX ($48.50M), PCVX ($37.47M).

How large is Jones Hill Capital LP's portfolio?

Jones Hill Capital LP reported $466.47M of long equity holdings across 26 positions as of 2026-Q1. Top-10 holdings account for 73.1% of reported value.

What is Jones Hill Capital LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/jones-hill-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →